Unicycive Therapeutics
Price & Volume
Stats
See more52W Range | $3.40-$11 |
Market Cap | $69.9M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.74 |
News
See moreYahoo Finance • 7 hours ago
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Fraud Lawsuit – UNCY
Yahoo Finance • 7 hours ago
UNICYCIVE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors a Class Action Lawsuit Has Been Filed Against Unicycive Therapeutics, Inc. and Encourages Investors to Contact the Firm
About
CEO | Dr. Shalabh K. Gupta M.D., MPA |
Address | 4300 El Camino Real, Los Altos, CA, United States, 94022 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 22 |
